Nearly 1,000 people with advanced breast cancer were recorded during the three-year study. All participants had an aggressive form of breast cancer is known to increased levels of a protein human epidermal growth factor receptor 2 or HER-2. The protein promotes the growth of cancer cells, and plays a role in about 20 % of invasive breast cancer.
After two years, 65.4 % of T-DM1 ,, compared with 47.5 % of the participants to standard treatment. The difference, while a noteworthy trend, not a statistical benchmark to meet its predefined study design. A later analysis of the overall survival time is planned.‘courtesy kaisernetwork.org kaisernetwork.org reprint you can enjoy the full Kaiser Daily HIV / AIDS reporting indicate Search for and, or log of e-mail publish at service Kaiser Daily HIV / AIDS report for emperors network. Subject to a free service from of The Henry J. Imperial Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Therefore, many Displays First National Blood Transfusion center of to stop HIVNigerian on Friday producing its first national transfusion center in an effort to curb the spread of HIV in the country, BBC News reports . The center, which is jointly funded by the U.S. Organization Secure Blood for Bank Africa Foundation and to the Nigerian Health Ministry is an from seven that the Ministry of and SBFA the country in the country .